Tag: ALS

MIND-presenters-599x400

Event Highlights Progress on Brain Disease Research

Determined collaboration and groundbreaking technology have led to exciting advances in efforts to solve the challenges of brain diseases, researchers from the MassGeneral Institute for Neurodegenerative Diseases(MIND) told patients, families and friends recently. On May 16, 2018, nearly 100 people attended the event at the MIND labs at the Charlestown Navy Yard. MIND’s Visiting Day gathering […]

Continue Reading
Natassi-ALS-image

New Imaging Protocol Could Vastly Accelerate Clinical Trials for New ALS Treatments

Researchers at Massachusetts General Hospital have developed a new technique for imaging the brains of patients with amyotrophic lateral sclerosis (ALS) that could vastly reduce the cost and time needed for new clinical trials—while also improving the accuracy of test results. Nazem Atassi, MD, the Associate Director of the Neurological Clinical Research Institute (NCRI) at […]

Continue Reading
53603741 - medicine doctor hand working with modern digital tablet computer interface as medical network concept

How New Biomarkers and Smartphone Apps Could Provide New Hope for ALS Patients

When a patient has strep throat, their care provider knows which antibiotics to prescribe to cure the ailment. But when a disease has no known cure, as is the case with amyotrophic lateral sclerosis (ALS), research often becomes part of clinical care. “There are still a lot of limitations in terms of what we can […]

Continue Reading
27915588 - dna background

Can Studying a Rare Inherited Form of ALS Lead to Earlier Diagnosis and New Treatments?

Hereditary forms of amyotrophic lateral sclerosis (ALS) may only account for 10 percent of all ALS cases, but the insights that researchers gain from studying this small population may be the key to unlocking new treatments for this devastating disease. That’s the hope of Katharine Nicholson, MD, a physician-investigator at the Neurological Clinical and Research […]

Continue Reading
Abstract 3d rendering of chaotic structure. Light background with lines and spheres in empty space. Futuristic shape.

Online Platform Accelerates Rare Disease Research

Earlier this week, the Mass General Neurological Clinical Research Center (NCRI)’s  NeuroBANK™ won Bio-IT World‘s Best Practice award in the Personalized & Translational Medicine category. What is the NeuroBANK, and how is it helping to accelerate the discovery, development, and delivery of future treatments for rare diseases including amyotrophic lateral sclerosis (ALS)? Filling a Need […]

Continue Reading
40379545 - interconnected neurons transferring information with electrical pulses.

Paganoni Advances ALS Research and Care with Technology

Technological advancements have revolutionized nearly every field of medicine from orthopedics to genetic testing. Sabrina Paganoni, MD, PhD, a clinician and researcher in the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital, has seen firsthand the potential power and impact technology could have for amyotrophic lateral sclerosis (ALS). Paganoni is using technology to find […]

Continue Reading
NCRIgroup_650x400

Mass General Investigators on the Cutting Edge of ALS Research

May is ALS Awareness Month, intended as a time to raise awareness of and foster research for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually these motor neurons die, effecting a patient’s ability to move, eat, […]

Continue Reading

TRACK ALS Succeeds in Measuring Brain Inflammation Using a PET Scan and Biomarker – ALS News Today

One big challenge in developing treatments for ALS is that there is no reliable way to track the progression of the disease in the brain and gauge the effectiveness of new treatments. However, researchers at Mass General were recently able to use a radiotracer to track neural inflammation—a key indicator of the disease—in ALS patients. This technique could help […]

Continue Reading

PET Theories: New Imaging Tools Offer Better Diagnosis, Treatment of Neurodegeneration

PET scanning is giving Mass General Hospital researchers a whole new view of neurodegenerative diseases, which will hopefully make it easier to diagnose and treat patients for a variety of conditions, including ALS and Parkinson’s disease. LEARN MORE

Continue Reading